1,831 Shares in Aflac Incorporated (NYSE:AFL) Purchased by Regent Peak Wealth Advisors LLC

Regent Peak Wealth Advisors LLC purchased a new position in Aflac Incorporated (NYSE:AFLFree Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 1,831 shares of the financial services provider’s stock, valued at approximately $205,000.

A number of other hedge funds also recently bought and sold shares of the business. Nordea Investment Management AB grew its stake in Aflac by 6.7% in the 1st quarter. Nordea Investment Management AB now owns 1,806,475 shares of the financial services provider’s stock valued at $155,140,000 after acquiring an additional 113,226 shares during the period. Czech National Bank grew its position in shares of Aflac by 6.4% in the second quarter. Czech National Bank now owns 98,535 shares of the financial services provider’s stock valued at $8,800,000 after purchasing an additional 5,912 shares during the period. State Board of Administration of Florida Retirement System increased its stake in shares of Aflac by 3.3% during the first quarter. State Board of Administration of Florida Retirement System now owns 718,067 shares of the financial services provider’s stock worth $61,653,000 after purchasing an additional 22,637 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in shares of Aflac by 13.9% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 708,248 shares of the financial services provider’s stock worth $60,810,000 after purchasing an additional 86,578 shares during the last quarter. Finally, M&G Plc purchased a new position in Aflac in the 2nd quarter valued at about $2,535,000. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Aflac Trading Down 0.0 %

AFL stock traded down $0.05 during midday trading on Wednesday, hitting $113.94. 307,430 shares of the company’s stock were exchanged, compared to its average volume of 2,238,439. Aflac Incorporated has a 1-year low of $75.07 and a 1-year high of $115.50. The business has a 50-day simple moving average of $108.55 and a two-hundred day simple moving average of $95.36. The stock has a market capitalization of $64.74 billion, a PE ratio of 12.58, a P/E/G ratio of 2.62 and a beta of 0.95. The company has a current ratio of 0.10, a quick ratio of 0.10 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFLGet Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.60 by $0.23. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The firm had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $4.10 billion. During the same period last year, the company earned $1.58 EPS. The company’s quarterly revenue was down .7% on a year-over-year basis. On average, sell-side analysts predict that Aflac Incorporated will post 6.76 EPS for the current fiscal year.

Aflac Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 2nd. Stockholders of record on Wednesday, August 21st were issued a $0.50 dividend. The ex-dividend date of this dividend was Wednesday, August 21st. This represents a $2.00 annualized dividend and a dividend yield of 1.76%. Aflac’s dividend payout ratio is currently 22.08%.

Insider Buying and Selling

In related news, Director Thomas J. Kenny sold 2,000 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total transaction of $197,880.00. Following the completion of the transaction, the director now directly owns 18,158 shares in the company, valued at $1,796,552.52. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.90% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

AFL has been the subject of a number of research analyst reports. Barclays assumed coverage on Aflac in a report on Wednesday, September 4th. They set an “underweight” rating and a $96.00 target price for the company. Piper Sandler upped their target price on shares of Aflac from $114.00 to $122.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. Evercore ISI raised their price target on shares of Aflac from $84.00 to $90.00 and gave the stock an “underperform” rating in a research note on Thursday, September 26th. Truist Financial increased their price objective on shares of Aflac from $82.00 to $100.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Finally, Jefferies Financial Group decreased their target price on shares of Aflac from $84.00 to $83.00 and set a “hold” rating on the stock in a research note on Friday, June 28th. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Aflac has an average rating of “Hold” and an average price target of $97.53.

View Our Latest Research Report on Aflac

Aflac Company Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Featured Articles

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFLFree Report).

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.